102623UK Continuous, Integrated Biologics Manufacturing ProjectClosedCollaborative R&DInnovate UKAs biopharma moves to the business mainstream, the industry will increasingly need to find new ways to maintain competitiveness by ensuring affordability, quality, and delivery performance. Continuous processes have been proposed as a solution as they are scalable, offer higher productivity with reduced running times and materials usage, and require smaller footprint and less capital intense facilities. The project brings together five leading biopharmaceutical companies with UK Operations, process technology suppliers and a Catapult centre to develop an automated continuous biologics purification unit for more efficient manufacture of a wide range of biologic drugs. The new unit will consist of integrated, multiple operations running concurrently.